JP2007520528A5 - - Google Patents

Download PDF

Info

Publication number
JP2007520528A5
JP2007520528A5 JP2006551846A JP2006551846A JP2007520528A5 JP 2007520528 A5 JP2007520528 A5 JP 2007520528A5 JP 2006551846 A JP2006551846 A JP 2006551846A JP 2006551846 A JP2006551846 A JP 2006551846A JP 2007520528 A5 JP2007520528 A5 JP 2007520528A5
Authority
JP
Japan
Prior art keywords
ring
alkyl
methyl
hydrogen
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006551846A
Other languages
English (en)
Japanese (ja)
Other versions
JP4778449B2 (ja
JP2007520528A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2005/050415 external-priority patent/WO2005075456A1/en
Publication of JP2007520528A publication Critical patent/JP2007520528A/ja
Publication of JP2007520528A5 publication Critical patent/JP2007520528A5/ja
Application granted granted Critical
Publication of JP4778449B2 publication Critical patent/JP4778449B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006551846A 2004-02-04 2005-02-01 Pde4インヒビターとしての2−(ピペリジン−4−イル)−4,5−ジヒドロ−2h−ピリダジン−3−オン誘導体 Expired - Fee Related JP4778449B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04002420 2004-02-04
EP04002420.0 2004-02-04
PCT/EP2005/050415 WO2005075456A1 (en) 2004-02-04 2005-02-01 2-(piperidin-4-yl) -4, 5-dihydro-2h-pyridazin-3-one derivatives as pde4 inhibitors

Publications (3)

Publication Number Publication Date
JP2007520528A JP2007520528A (ja) 2007-07-26
JP2007520528A5 true JP2007520528A5 (enExample) 2008-03-21
JP4778449B2 JP4778449B2 (ja) 2011-09-21

Family

ID=34833569

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006551846A Expired - Fee Related JP4778449B2 (ja) 2004-02-04 2005-02-01 Pde4インヒビターとしての2−(ピペリジン−4−イル)−4,5−ジヒドロ−2h−ピリダジン−3−オン誘導体

Country Status (9)

Country Link
US (2) US7494990B2 (enExample)
EP (1) EP1716133B1 (enExample)
JP (1) JP4778449B2 (enExample)
AT (1) ATE390419T1 (enExample)
AU (1) AU2005210042B2 (enExample)
CA (1) CA2554797C (enExample)
DE (1) DE602005005638T2 (enExample)
ES (1) ES2304692T3 (enExample)
WO (1) WO2005075456A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013234404B2 (en) * 2007-05-16 2016-04-28 Takeda Gmbh Pyrazolone Derivatives as PDE4 Inhibitors
ME00952B (me) 2007-05-16 2012-06-20 Takeda Gmbh Derivati pirazolona kao pde4 inhibitori
AR074318A1 (es) * 2008-11-14 2011-01-05 Nycomed Gmbh Derivados heterociclicos de pirazolona, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de enfermedades de las vias respiratorias.
JP5980318B2 (ja) 2011-06-17 2016-08-31 タケダ ゲー・エム・ベー・ハーTakeda GmbH 新規のフタラジノン−ピロロピリミジンカルボキサミド誘導体

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB858792A (en) * 1958-02-10 1961-01-18 Sandoz Ltd New pyridazine derivatives and processes for their manufacture
US5267027A (en) * 1991-04-30 1993-11-30 Sanyo Electric Co., Ltd. Comb filter-type Y/C separator circuit
ATE183745T1 (de) 1991-10-09 1999-09-15 Syntex Inc Pyrido pyridazinon und pyridazinthionverbindungen mit pde iv inhibierender wirkung
DE4134893A1 (de) 1991-10-23 1993-04-29 Merck Patent Gmbh Thiadiazinone
DE4310699A1 (de) * 1993-04-01 1994-10-06 Merck Patent Gmbh Thiadiazinone
US5798349A (en) 1994-03-14 1998-08-25 The General Hospital Corporation Use of green porphyrins to treat neovasculature in the eye
DE19502699A1 (de) * 1995-01-28 1996-08-01 Merck Patent Gmbh Arylalkyl-thiadiazinone
DE19514568A1 (de) * 1995-04-20 1996-10-24 Merck Patent Gmbh Arylalkyl-pyridazinone
DE19533975A1 (de) * 1995-09-14 1997-03-20 Merck Patent Gmbh Arylalkyl-diazinone
DE19604388A1 (de) 1996-02-07 1997-08-14 Merck Patent Gmbh Arylalkyl-diazinone
HUP0001541A3 (en) * 1997-01-15 2001-11-28 Altana Pharma Ag Phthalazinone derivatives and pharmaceutical compositions containing them
WO1999031071A1 (en) 1997-12-15 1999-06-24 Byk Gulden Lomberg Chemische Fabrik Gmbh New phthalazinones
US6380196B1 (en) * 1997-12-15 2002-04-30 Byk Gulden Lomberg Chemische Fabrik Gmbh Dihydrobenzofurans
US6255303B1 (en) * 1998-03-14 2001-07-03 Byk Gulden Lomberg Chemische Fabrik Gmbh Phthalazinone PDE III/IV inhibitors
AU7654200A (en) 1999-09-14 2001-04-17 Byk Gulden Lomberg Chemische Fabrik Gmbh Phthalazinone derivatives as pd3/4 inhibitors
EP1244654A1 (en) 1999-10-25 2002-10-02 ALTANA Pharma AG Tetrahydrothiopy ranphthalazinone derivatives as pde4 inhibitors
CA2388121A1 (en) 1999-10-25 2001-05-03 Byk Gulden Lomberg Chemische Fabrik Gmbh Phthalazinone derivatives as pde 4 inhibitors
NZ522882A (en) * 2000-06-05 2004-07-30 Altana Pharma Bv Pyridazinone compounds effective as beta-2-adrenoreceptor agonists as well as PDE4-inhibitors
EA200300836A1 (ru) * 2001-02-15 2004-02-26 Алтана Фарма Аг Производные фталазинон-пиперидина в качестве ингибиторов pde4
SK14352003A3 (sk) * 2001-04-25 2004-04-06 Altana Pharma Ag Piperazino-deriváty, farmaceutický prostriedok s ich obsahom a ich použitie
PL363312A1 (en) * 2001-04-25 2004-11-15 Altana Pharma Ag Novel phthalazinones
DE10150517A1 (de) 2001-10-12 2003-04-17 Merck Patent Gmbh Verwendung von Phosphodiesterase IV-Inhibitoren
JP2005538138A (ja) 2002-08-10 2005-12-15 アルタナ ファルマ アクチエンゲゼルシャフト Pde4インヒビターとしてのピリダジノン誘導体
KR101131684B1 (ko) * 2002-08-10 2012-03-28 니코메드 게엠베하 Pde4 억제제로서의 피롤리딘디온 치환된피페리딘-프탈라존
WO2004018449A1 (en) 2002-08-10 2004-03-04 Altana Pharma Ag Piperidine-derivatives as pde4 inhibitors
PL373597A1 (en) 2002-08-10 2005-09-05 Altana Pharma Ag Piperidine-n-oxide-derivatives
WO2004017957A1 (en) 2002-08-20 2004-03-04 Protemix Corporation Limited Preventing and/or treating cardiovascular disease and/or associated heart failure
US20080227790A1 (en) 2004-02-04 2008-09-18 Altana Pharma Ag Pyridazinone Derivatives and their Use as Pde4 Inhibitors
WO2005075457A1 (en) 2004-02-04 2005-08-18 Altana Pharma Ag Phthalazinone-derivatives as pde4 inhibitors

Similar Documents

Publication Publication Date Title
AR045180A1 (es) Derivados 3-amino cromado y 2-amino tetralina y composiciones que contienen a dichos compuestos
YU35603A (sh) Derivati benzodiazepina kao modulatori gaba a receptora
JP2012503008A5 (enExample)
BR122012009489B8 (pt) processo para produzir 2-etóxi-1-{[2’-(5-oxo-4,5-diidro-1,2,4-oxadiazol-3-il)bifenil-4-il]metil}-1h-benzimidazol-7-carboxilato de (5-metil-2-oxo-1,3-dioxol-4-il)metila ou um sal do mesmo, composição farmacéutica, e, uso
CA2526866A1 (en) Substituted 3-sulfur indoles for treating a disease mediated by crth2
WO2007060257A3 (en) Diketopyrrolo-pyrrole compounds
JP2007508359A5 (enExample)
RU2008144806A (ru) 4-анилинохинолин-3-карбоксамиды в качестве ингибиторов csf-1r киназы
JP2008540637A5 (enExample)
WO2006021656A3 (fr) Derives d'amino- piperidine , leur preparation et leur application en tant qu'agonistes des recepteurs aux melanocortines
MEP22008A (en) Derivatives of n-[heteroaryl(piperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics
TW200745029A (en) Sulfonamide derivatives exhibiting PGD2 receptor antagonism
AR055165A1 (es) Inhibidores ns5b de vhc de indolobenzacepina, composiciones farmaceuticas que los contienen y su uso en el tratamiento de la hepatitis c.
JP2008530099A5 (enExample)
JP2012528166A5 (enExample)
AR054787A1 (es) Derivados de piperidinas utiles como antagonistas de histamina h3
TW200738706A (en) Pyrido-, pyrazo-and pyrimido-pyrimidine derivatives and their use as mTOR inhibitors
IL189069A0 (en) Piperidine and piperazine derivatives as p2x3 antagonists
PE20081577A1 (es) Derivados de sulfonamida ciclicos como inhibidores de la recaptacion de monoamina
JP2007513901A5 (enExample)
HRP20070430T3 (en) (3-oxo-3,4-dihydro-quinoxalin-2-yl-amino)-benzamide derivatives and related compounds as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity
AR084913A1 (es) Derivados de aril-benzocicloalquil-amida
BRPI0608732A2 (pt) composto ou um sal, hidrato, solvato, complexo ou pró-droga farmaceuticamente aceitável do mesmo, sal de um composto, processo para a preparação de um composto, uso de um composto, composição farmacêutica, e, produto
TW200800938A (en) Indole carboxylic acid derivatives exhibiting PGD2 receptor antagonism
EA201071012A1 (ru) Производные азетидинов, способ их получения и применение их в терапии